AstraZeneca (LSE:AZN)
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
About
Last updated 25-02-2021, 04:30:00pm GMTRelated Articles
-
Shares to buy now: why I’d consider Lloyds Banking Group alongside this FTSE 100 stock
Since July, this FTSE 100 company's share price has been trending down. But the decline is at odds with the progress of the underlying... Read More »
-
AstraZeneca share price: is this FTSE 100 growth stock now a top ‘dip buy’?
The AstraZeneca share price has underperformed the FTSE 100 in recent months. G A Chester weighs up its dip-buy credentials. Read More »
-
The AstraZeneca share price: why I’d buy and hold the stock
The AstraZeneca share price has an attractive long-term outlook, thanks to its expansive portfolio of drugs and new treatments. Read More »
-
AstraZeneca: why I’m forgetting the headlines and following the trendlines
AstraZeneca is forging ahead with its portfolio of ‘on trend’ medicines that should prove increasingly profitable. Read More »
-
AstraZeneca shares: 4 reasons I’d buy them now
The AZN share price has been subdued for the last few months, but Manika Premsingh thinks that’s about to change. Read More »
-
FTSE 100 shares to buy: AstraZeneca has rediscovered its growth mojo
Here's why I like the look of AstraZeneca shares today and I think the investment risks are balanced by the potential for the business... Read More »
-
Top British stocks for February 2021
We asked our freelance writers to share their top British stocks for February, including Lloyds Banking Group and Computacenter. Read More »
-
Events I think that could send AstraZeneca shares rallying in 2021
Given the start of 2021, Jay Yao writes what he thinks are events that could send AstraZeneca shares potentially higher this year Read More »
-
My 2 best shares for 2021
As the New Year starts, now is the perfect time to look for investments that should do well this year. Here are two of... Read More »
-
AstraZeneca shares: Hargreaves Lansdown investors are buying. Should I buy too?
AstraZeneca shares have fallen by more than 25% since last summer. Roland Head has been taking a fresh look. Is the pharma giant too... Read More »